ICU Medical, Inc., was incorporated by its CEO in 1984 and made its initial public offering in 1992. The company is a leader in the development, production and sales of new medical devices for injection therapy, oncology and emergency care. The company's products improve patient recovery by helping to organize blood pressure infections, protecting healthcare workers and patients from exposure to infectious diseases or harmful drugs, and monitoring continuous cardiac output of emergency care patients. The company's complete product line includes custom injection systems, closed delivery systems for hazardous drugs, needle-free injection connectors, catheters and cardiac detection systems.
